Laboratory Corp. of America Holdings COO James T. Jr. Boyle Sells 38,600 Shares (LH)
Laboratory Corp. of America Holdings (NYSE:LH) COO James T. Jr. Boyle sold 38,600 shares of the stock in a transaction dated Monday, June 9th. The shares were sold at an average price of $103.00, for a total value of $3,975,800.00. Following the transaction, the chief operating officer now directly owns 25,821 shares of the company’s stock, valued at approximately $2,659,563. The transaction was disclosed in a legal filing with the SEC, which is available at this link.
A number of research firms have recently commented on LH. Analysts at Zacks reiterated a “neutral” rating on shares of Laboratory Corp. of America Holdings in a research note on Tuesday, May 20th. They now have a $105.00 price target on the stock. Separately, analysts at Cantor Fitzgerald reiterated a “buy” rating on shares of Laboratory Corp. of America Holdings in a research note on Friday, May 9th. They now have a $115.00 price target on the stock, up previously from $105.00. Finally, analysts at Mizuho raised their price target on shares of Laboratory Corp. of America Holdings from $89.00 to $104.00 in a research note on Wednesday, April 2nd. They now have a “neutral” rating on the stock. Eleven equities research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. The stock has an average rating of “Hold” and an average target price of $102.42.
Laboratory Corp. of America Holdings (NYSE:LH) traded down 0.28% during mid-day trading on Tuesday, hitting $102.73. 491,847 shares of the company’s stock traded hands. Laboratory Corp. of America Holdings has a 52 week low of $87.01 and a 52 week high of $108.00. The stock’s 50-day moving average is $100.4 and its 200-day moving average is $96.13. The company has a market cap of $8.712 billion and a price-to-earnings ratio of 17.14.
Laboratory Corp. of America Holdings (NYSE:LH) last released its earnings data on Monday, April 28th. The company reported $1.51 earnings per share for the quarter, missing the analysts’ consensus estimate of $1.58 by $0.07. The company had revenue of $1.43 billion for the quarter, compared to the consensus estimate of $1.45 billion. During the same quarter last year, the company posted $1.74 earnings per share. Laboratory Corp. of America Holdings’s revenue was down .7% compared to the same quarter last year. Analysts expect that Laboratory Corp. of America Holdings will post $6.67 EPS for the current fiscal year.
Laboratory Corporation of America Holdings is a clinical laboratory company in the United States. Through a national network of laboratories, the Company offers a range of testing services used by the medical profession in routine testing, patient diagnosis, and in the monitoring and treatment of disease.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.